Knight Initiative News

Research by Kati Andreasson and colleagues suggests that a type of drug developed for treating cancer may hold promise as a new treatment for neurodegenerative disorders such as Alzheimer’s.

A drug that restores brain metabolism in mouse models of Alzheimer's also improved cognitive function, according to research from the Andreasson lab.

It may feel like you’re being more productive, but experts like Anthony Wagner say you’re not.

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease, but which also carry safety risks according to Knight Initiative for Brain Resilience affiliate Mike Greicius and others.

Researchers are closer to having a more precise method for efficiently treating depression, a new study suggests.

Wu Tsai Neuro affiliate Michelle Monje and team discovered that adaptive myelination, a form of brain plasticity, contributes to drug addiction. A single morphine dose in mice triggered myelination in reward-related brain circuits, reinforcing drug-seeking behavior. Blocking this myelination prevented addiction, highlighting potential new treatment strategies.

Wu Tsai Neuro and Knight Initiative for Brain Resilience affiliate, Michael Greicius, and others share their expertise on the limitations of the Alzheimer's drug Leqembi.

In this interview on the Huberman Lab podcast, Institute affiliate E.J. Chichilnisky discusses how studying the retina informs our understanding of the brain, the development of artificial retinas for treating incurable blindness, and his own personal journey.

A.I. models developed by members of Wu Tsai Neuro's Neuro-Omics Initiative are making surprising biological discoveries.

Wu Tsai Neuro affiliate Sharon Sha shared her expertise on Frontotemporal Dementia amid Wendy Williams' diagnosis.

Wu Tsai Neuro faculty scholar Paul Nuyujukian shares his expertise on brain-computer interfaces amid Neuralink's first human brain implant.

The International Society for Stem Cell Research awards Sergiu P. Paşca the 2024 ISSCR Momentum Award for his achievements in neurodevelopment and disease.

Even just one night of less than six hours of rest can impair short-term memory according to experts, including Wu Tsai Neuro affiliate Sharon Sha.

NBC Bay Area’s Raj Mathai spoke to Wu Tsai Neuro Institute Scholar Paul Nuyujukian for insight on the first brain chip in a human patient.

Institute Scholar Paul Nuyujukian contributes to the discussion of Neuralink implanting a brain chip into a human.

In a live interview, Wu Tsai Neuro Institute Scholar Paul Nuyujukian tells NBC News how Neuralink technology works and the future of brain-computer interfaces.

A 3D variation of pooled CRISPR screens could connect the dots between autism spectrum disorder genetics and cell fate pathways in the developing brain.

Neuroscientists have long been frustrated that they cannot access or examine brain tissue. But by reserve-engineering cells in the lab, Sergiu Pașca can now study brain disorders on a molecular level.

How to know if your organs are ‘older’ than you are, and ways to slow down biological aging according to Knight Initiative director Tony Wyss-Coray and others.

Knight Initiative director Tony Wyss-Coray and others are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age.